Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as chitosan
View Patent ↗Improved hemostatic agents take the form of granules or particles that can be used to stanch, seal, or stabilize a site of hemorrhage, including a noncompressible hemorrhage.
1. A hemostatic chitosan material in granule or particle form having a density between about 0.25 to 0.60 g/cm 3 and a granule or particle diameter of about 0.9 mm, wherein said granules or particles are produced by freeze-drying a frozen matrix of chitosan, heat-compressing said matrix, and then granulating the compressed matrix.
2. The hemostatic chitosan material of claim 1 , wherein the at least one of the granules or particles includes dense chitosan beads.
3. The hemostatic chitosan material of claim 1 , wherein the density of the hemostatic chitosan material in the form of a granule or particle is between about 0.25 to 0.50 g/cm3.
4. The hemostatic chitosan material of claim 1 , further comprising a chitosan salt.
5. The hemostatic chitosan material of claim 4 , wherein the chitosan salt is selected from the group consisting of chitosan acetate, chitosan lactate, and chitosan hydroxyacetate.
6. A hemostatic device comprising a mesh socklet and the hemostatic chitosan material of claim 1 .
7. The hemostatic device of claim 6 , wherein the device further comprises strips of a polymer mesh material.
8. The hemostatic device of claim 6 , wherein the mesh socklet comprises a polymer material.
9. The hemostatic device of claim 6 , wherein the mesh socklet comprises openings sized to allow for the granules or particles to protrude out of the mesh socklet.
10. The hemostatic device of claim 6 , wherein the density of the chitosan material in the form of a granule or particle is between about 0.25 to 0.50 g/cm3.
11. The hemostatic device of claim 6 , wherein the chitosan material comprises a chitosan salt.
12. The hemostatic device of claim 11 , wherein the chitosan salt is selected from the group consisting of chitosan acetate, chitosan lactate, and chitosan hydroxyacetate.
13. The hemostatic device of claim 6 , further comprising a cannula.
14. The hemostatic device of claim 6 , further comprising a syringe.
15. A hemostatic agent comprising chitosan or chitin crustacean shell material which has been at least partially or fully deproteinized, and partially or fully deacetylized, wherein the chitosan or crustacean shell material is ground into granule or particle form, and wherein the chitosan or chitin granules or particles are expanded and partially ruptured such that about two-thirds of an interior of a granule or particle radius is intact and about a remaining one-third of the granule or particle radius is expanded at the surface of said granule or particle.
16. The hemostatic agent of claim 15 , wherein the granule or particle form is fully deproteinized and partially or fully deacetylized chitosan material.
17. The hemostatic agent of claim 16 , wherein the chitosan material comprises a chitosan salt.
18. The hemostatic agent of claim 17 , wherein the chitosan salt is selected from the group consisting of chitosan acetate, chitosan lactate, and chitosan hydroxyacetate.